A DNA adjuvant encoding a fusion protein between anti-CD3 single-chain Fv and AIMP1 enhances T helper type 1 cell-mediated immune responses in antigen-sensitized mice

Immunology

Volumn 126, Issue 1, 2009, Pages 84-91

  Lee, Byeong Cheol ^a   O'Sullivan, Insug ^b   Kim, Eugene ^a   Park, Sang Gyu ^c   Hwang, Seung Yong ^d   Cho, Daeho ^e   Kim, Tae Sung ^a  

^a Korea University   (South Korea)

^b UNIVERSITY OF ILLINOIS   (United States)

^c Seoul National University Hospital   (South Korea)

^d Hanyang University   (South Korea)

^e Sookmyung Women's University   (South Korea)

Author keywords

Aminoacyl t RNA synthetase interacting multifunctional protein 1; Anti CD3; DNA adjuvant; T cell; T helper cell response

Indexed keywords

CD3 ANTIBODY; DNA; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; OVALBUMIN; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; DNA; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN VARIABLE REGION; INJECTIONS, INTRAMUSCULAR; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; OVALBUMIN; RECOMBINANT FUSION PROTEINS; SPLEEN; TH1 CELLS;

EID: 57449111275     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.02880.x     Document Type: Article

References (35)

1. Glimcher LH, Murphy KM. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev 2002 14 : 1693 711.
2. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003 8 : 223 46.
3. Knutson KL, Disis ML. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol Immunother 2005 54 : 721 8.
4. Foulds KE, Wu CY, Seder RA. Th1 memory: implication for vaccine development. Immunol Rev 2006 211 : 58 66.
5. Zhang Y, Wakita D, Chamoto K et al. Th1 cell adjuvant therapy combined with tumor vaccination: a novel strategy for promoting CTL responses while avoiding the accumulation of Tregs. Int Immunol 2007 19 : 151 61.
6. Fields PE, Kim ST, Flavell RA. Cutting edge: changes in histone acetylation at the IL-4 and IFN-gamma loci accompany Th1/Th2 differentiation. J Immunol 2002 169 : 647 50.
7. Szabo SJ, Sullivan BM, Peng SL, Glimcher LH. Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol 2003 21 : 713 58.
8. + T cells. Immunol Res 2006 36 : 275 82.
9. Laouar Y, Sutterwala FS, Gorelik L, Flavell RA. Transforming growth factor beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat Immunol 2005 6 : 600 7.
10. Lee SW, Cho BH, Park SG, Kim S. Aminoacyl-tRNA synthetase complexes: beyond translation. J Cell Sci 2004 117 : 3725 34.
11. Park SG, Ewalt KL, Kim S. Functional expansion of aminoacyl-tRNA synthetases and their interacting factors: new perspectives on housekeepers. Trends Biochem Sci 2005 30 : 569 74.
12. Park SG, Kang YS, Kim JY et al. Hormonal activity of AIMP1/p43 for glucose homeostasis. Proc Natl Acad Sci USA 2006 103 : 14913 8.
13. + T cells. J Immunol 2006 176 : 256 64.
14. Kim E, Kim SH, Kim S, Cho D, Kim TS. AIMP1/p43 protein induces the maturation of bone marrow-derived dendritic cells with T helper type 1-polarizing ability. J Immunol 2008 180 : 2894 902.
15. Gurunathan S, Klinman DM, Seder RA. DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 2000 18 : 927 74.
16. Liu MA, Wahren B, Karlsson Hedestam GB. DNA vaccines: recent developments and future possibilities. Hum Gene Ther 2006 17 : 1051 61.
17. Jiang W, Pisetsky DS. Enhancing immunogenicity by CpG DNA. Curr Opin Mol Ther 2003 5 : 180 5.
18. Crameri R, Rhyner C. Novel vaccines and adjuvants for allergen-specific immunotherapy. Curr Opin Immunol 2006 18 : 761 8.
19. Huygen K. DNA vaccines against mycobacterial diseases. Future Microbiol 2006 1 : 63 73.
20. Lowe DB, Shearer MH, Jumper CA, Kennedy RC. Towards progress on DNA vaccines for cancer. Cell Mol Life Sci 2007 64 : 2391 403.
21. Kim EJ, Cho D, Hwang SY, Kim TS. Interleukin-2 fusion protein with anti-CD3 single-chain Fv (sFv) selectively protects T cells from dexamethasone-induced apoptosis. Vaccine 2001 20 : 608 15.
22. Reff ME, Garner K, Chambers KS et al. Depletion of B cells in vivo by chimeric mouse human monoclonal antibody to CD20. Blood 1994 83 : 435 45.
23. Wolff JA, Malone RW, Williams P et al. Direct gene transfer into mouse muscle in vivo. Science 1990 247 : 1465 8.
24. + T cells from a Th1 to a Th2 response. Immunology 2003 109 : 407 14.
25. Kim TS, DeKyuyff RH, Rupper R, Maecker HT, Levy S, Umetsu DT. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production. J Immunol 1997 158 : 4137 44.
26. Ferrera F, La Cava A, Hahn BH, Indiveri E, Filaci G. Gene vaccination for the immune tolerance. Ann N Y Acad Sci 2007 1110 : 99 111.
27. Wolff JA, Budker V. The mechanism of naked DNA uptake and expression. Adv Genet 2005 54 : 3 20.
28. Whitton JL, Yokoyama M. Proteins expressed by DNA vaccines induce both local and systemic immune responses. Ann N Y Acad Sci 1996 797 : 196 206.
29. Tsang C, Babiuk S, Van Drunen Little-van den Hurk S, Babiuk LA, Griebel P. A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months. Vaccine 2007 25 : 5485 94.
30. Greenland JR, Letvin NL. Chemical adjuvants for plasmid DNA vaccines. Vaccine 2007 25 : 3731 41.
31. Gillies SD, Young D, Lo KM, Roberts S. Biological activity and in vivo clearance of antitumor antibody/cytokine fusion proteins. Bioconjug Chem 1993 4 : 230 5.
32. Tsuji-Takayama K, Aizawa Y, Okamoto I et al. Interleukin-18 induces interferon-γ production through NF-κB and NF-AT activation in murine T helper type 1 cells. Cell Immunol 1999 196 : 41 50.
33. Li Q, Carr AL, Donald EJ, Skitzki JJ et al. Synergistic effects of IL-12 and IL-18 in skewing tumor-reactive T-cell responses toward a type 1 pattern. Cancer Res 2005 65 : 1063 70.
34. Tasaki K, Yoshida Y, Maeda T et al. Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells. Cancer Gene Ther 2000 7 : 247 54.
35. Larche M. Immunoregulation by targeting T cells in the treatment of allergy and asthma. Curr Opin Immunol 2006 18 : 745 50.